[Congressional Record Volume 167, Number 92 (Wednesday, May 26, 2021)]
[Senate]
[Pages S3492-S3496]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                    ENDLESS FRONTIER ACT--Continued


                Amendment No. 1588 to Amendment No. 1502

  Mr. COONS. Mr. President, I rise to call up my amendment No. 1588, 
which is cosponsored by Senators Graham and Lujan, Barrasso, and 
Collins.
  This amendment would establish a Foundation for Energy Security and 
Innovation, a nonprofit Foundation to support the Department of 
Energy's mission to help raise private capital to accelerate the 
commercialization of new and cutting-edge technologies.
  As China has dramatically ramped up their R&D funding, our Federal 
funding has remained stagnant, threatening U.S. competitiveness and our 
potential to develop, bring to scale, and export clean energy 
technologies.
  This amendment will take a model already proven by Foundations 
affiliated with the NIH, the CDC, the Department of Agriculture, and 
create a Foundation to channel private sector investments into our 
world-class scientific innovation institutions, our National Labs.
  This new Foundation would support the great work already happening at

[[Page S3493]]

the Department of Energy by leveraging public-private partnerships to 
address tech transfer barriers.
  Working on this bill over the years, I have heard significant 
interest from the private sector and philanthropists looking for an 
entity to coordinate their investment.
  This bipartisan and bicameral bill passed the House last year with 
the leadership of now Senator Lujan, and I urge my colleagues to 
support its passage.
  I want to thank my partners, Senators Graham and Lujan, for their 
leadership and thank Senators Barrasso and Collins for cosponsoring, 
Senators Schumer and Manchin for their support, and Senators Wicker, 
Cantwell, and Young for their leadership on the Endless Frontier Act.
  I yield the floor.
  The PRESIDING OFFICER. The clerk will report the amendment by number.
  The senior assistant legislative clerk read as follows:

       The Senator from Delaware [Mr. Coons] proposes an amendment 
     numbered 1588 to amendment No. 1502.

  (The amendment is printed in the Record of May 19, 2021 under ``Text 
of Amendments.'')


                       Vote on Amendment No. 1588

  The PRESIDING OFFICER. The question is on agreeing to the amendment.
  Mr. COONS. Mr. President, I ask for the yeas and nays.
  The PRESIDING OFFICER. Is there a sufficient second?
  There appears to be a sufficient second.
  The clerk will call the roll.
  The legislative clerk called the roll.
  Mr. DURBIN. I announce that the Senator from West Virginia (Mr. 
Manchin) is necessarily absent.
  Mr. THUNE. The following Senators are necessarily absent: the Senator 
from Tennessee (Mrs. Blackburn) and the Senator from North Carolina 
(Mr. Tillis).
  The PRESIDING OFFICER (Ms. Baldwin). Are there any other Senators in 
the Chamber desiring to vote?
  The result was announced--yeas 83, nays 14, as follows:

                      [Rollcall Vote No. 210 Leg.]

                                YEAS--83

     Baldwin
     Barrasso
     Bennet
     Blumenthal
     Blunt
     Booker
     Boozman
     Braun
     Brown
     Burr
     Cantwell
     Capito
     Cardin
     Carper
     Casey
     Cassidy
     Collins
     Coons
     Cornyn
     Cortez Masto
     Cotton
     Cramer
     Daines
     Duckworth
     Durbin
     Ernst
     Feinstein
     Fischer
     Gillibrand
     Graham
     Grassley
     Hassan
     Heinrich
     Hickenlooper
     Hirono
     Hoeven
     Hyde-Smith
     Inhofe
     Kaine
     Kelly
     Kennedy
     King
     Klobuchar
     Lankford
     Leahy
     Lujan
     Markey
     McConnell
     Menendez
     Merkley
     Moran
     Murkowski
     Murphy
     Murray
     Ossoff
     Padilla
     Peters
     Portman
     Reed
     Romney
     Rosen
     Rounds
     Rubio
     Sanders
     Sasse
     Schatz
     Schumer
     Scott (SC)
     Shaheen
     Sinema
     Smith
     Stabenow
     Sullivan
     Tester
     Thune
     Van Hollen
     Warner
     Warnock
     Warren
     Whitehouse
     Wicker
     Wyden
     Young

                                NAYS--14

     Crapo
     Cruz
     Hagerty
     Hawley
     Johnson
     Lee
     Lummis
     Marshall
     Paul
     Risch
     Scott (FL)
     Shelby
     Toomey
     Tuberville

                             NOT VOTING--3

     Blackburn
     Manchin
     Tillis
  The PRESIDING OFFICER. On this vote, the yeas are 83, the nays are 
14.
  Under the previous order requiring 60 votes for the adoption of this 
amendment, the amendment is agreed to.
  The amendment (No. 1588) was agreed to.


                Amendment No. 1929 to Amendment No. 1502

  Mr. LEE. Madam President, I call up my amendment No. 1929 and ask 
that it be reported by number.
  The PRESIDING OFFICER. The clerk will report the amendment by number.
  The senior assistant legislative clerk read as follows:

       The Senator from Utah [Mr. Lee] proposes an amendment 
     numbered 1929 to amendment No. 1502.

  (The amendment is printed in the Record of May 24, 2021, under ``Text 
of Amendments.'')
  The PRESIDING OFFICER. There are now 2 minutes of debate, equally 
divided, on the amendment.
  The Senator from Utah.
  Mr. LEE. Madam President, the United States of America cannot 
meaningfully compete with Communist China. If our own government and if 
our own Federal regulatory system, one that 25 years ago was costing 
the American economy $300 billion a year and is now costing the 
American economy $2 trillion, if that regulatory system is hobbling us, 
we won't be able to compete.
  That is why I introduced this amendment No. 1929, to bring the focus 
of the debate back to where it belongs--back to our regulatory 
challenges. It sets up a Regulatory Oversight and Review Task Force, 
composed of OMB, OIRA, and people in the private sector with expertise 
in this area.
  The bipartisan task force would have, as its job, to conduct annually 
a review of all Federal regulations to figure out what is working, what 
is not working, what is harming American job growth, and what is 
helping.
  Congress would then have the opportunity to review these 
recommendations and review recommendations in a way that would 
ultimately bring about regulatory reform helping us to compete with 
Communist China.
  We can't beat China at its own game. We have to beat China by being 
our best selves. That is what amendment 1929 will do.
  The PRESIDING OFFICER. The Senator from Michigan.
  Mr. PETERS. Madam President, this measure undermines Federal 
Agencies' efforts to protect workers, consumers, our environment, and 
public health. When Federal Agencies create regulations, they must look 
at the full range of costs and benefits, including the impact on 
employers, workers, and vulnerable groups.
  This measure shuts out most of these voices. It is designed to push 
Congress to repeal regulations without considering the concerns of 
workers who rely on Federal safety standards or communities whose water 
has been polluted by lead.
  If Congress is concerned about a regulation, we already have tools to 
make the needed changes--either passing a law or using procedures like 
the Congressional Review Act. We need to move forward on bipartisan 
policies that will improve our Nation's competitiveness, not measures 
that will endanger our constituents and our communities. I urge my 
colleagues to vote no on amendment 1929.


                       Vote on Amendment No. 1929

  Mr. LEE. I ask for the yeas and nays.
  The PRESIDING OFFICER. The question is on agreeing to the amendment.
  Is there a sufficient second?
  Mr. DURBIN. Madam President.
  The PRESIDING OFFICER. The Democratic whip.
  Mr. DURBIN. Madam President, I ask unanimous consent the remaining 
votes tonight be 10-minute votes.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  Is there a sufficient second?
  There appears to be a sufficient second.
  The clerk will call the roll.
  The senior assistant legislative clerk called the roll.
  Mr. DURBIN. I announce that the Senator from West Virginia (Mr. 
Manchin) is necessarily absent.
  Mr. THUNE. The following Senators are necessarily absent: the Senator 
from Tennessee (Mrs. Blackburn) and the Senator from North Carolina 
(Mr. Tillis).
  The PRESIDING OFFICER. Are there any other Senators in the Chamber 
desiring to vote?
  The result was announced--yeas 48, nays 49, as follows:

                      [Rollcall Vote No. 211 Leg.]

                                YEAS--48

     Barrasso
     Blunt
     Boozman
     Braun
     Burr
     Capito
     Cassidy
     Collins
     Cornyn
     Cotton
     Cramer
     Crapo
     Cruz
     Daines
     Ernst
     Fischer
     Graham
     Grassley
     Hagerty
     Hawley
     Hoeven
     Hyde-Smith
     Inhofe
     Johnson
     Kennedy
     Lankford
     Lee
     Lummis
     Marshall
     McConnell
     Moran
     Murkowski
     Paul
     Portman
     Risch
     Romney
     Rounds
     Rubio
     Sasse
     Scott (FL)
     Scott (SC)
     Shelby
     Sullivan
     Thune
     Toomey
     Tuberville
     Wicker
     Young

                                NAYS--49

     Baldwin
     Bennet
     Blumenthal
     Booker
     Brown
     Cantwell
     Cardin
     Carper
     Casey

[[Page S3494]]


     Coons
     Cortez Masto
     Duckworth
     Durbin
     Feinstein
     Gillibrand
     Hassan
     Heinrich
     Hickenlooper
     Hirono
     Kaine
     Kelly
     King
     Klobuchar
     Leahy
     Lujan
     Markey
     Menendez
     Merkley
     Murphy
     Murray
     Ossoff
     Padilla
     Peters
     Reed
     Rosen
     Sanders
     Schatz
     Schumer
     Shaheen
     Sinema
     Smith
     Stabenow
     Tester
     Van Hollen
     Warner
     Warnock
     Warren
     Whitehouse
     Wyden

                             NOT VOTING--3

     Blackburn
     Manchin
     Tillis
  The PRESIDING OFFICER. On this vote, the yeas are 48, the nays are 
49.
  Under the previous order requiring 60 votes for adoption of this 
amendment, the amendment is not agreed to.
  The amendment (No. 1929) was rejected.
  The PRESIDING OFFICER. The Senator from Indiana.


                Amendment No. 1771 to Amendment No. 1502

  Mr. BRAUN. Madam President, I call up my amendment No. 1771 and ask 
that it be reported by number.
  The PRESIDING OFFICER. The clerk will report.
  The bill clerk read as follows:

       The Senator from Indiana [Mr. Braun] proposes an amendment 
     numbered 1771 to amendment No. 1502.

  The amendment is as follows

 (Purpose: To amend title 18, United States Code, to prohibit certain 
                    types of human-animal chimeras)

       At the appropriate place, insert the following:

     SEC. __. PROHIBITION ON CERTAIN HUMAN-ANIMAL CHIMERAS.

       (a) In General.--Part I of title 18, United States Code, is 
     amended by inserting after chapter 51 the following:

    ``CHAPTER 52--CERTAIN TYPES OF HUMAN-ANIMAL CHIMERAS PROHIBITED

``Sec.
``1131. Definitions.
``1132. Prohibition on human-animal chimeras.

     ``Sec. 1131. Definitions

       ``In this chapter:
       ``(1) Human embryo.--The term `human embryo' means an 
     organism of the species Homo sapiens during the earliest 
     stages of development, from 1 cell up to 8 weeks after 
     conception.
       ``(2) Prohibited human-animal chimera.--The term 
     `prohibited human-animal chimera' means--
       ``(A) a human embryo into which a nonhuman cell or cells 
     (or the component parts thereof) have been introduced to 
     render the embryo's membership in the species Homo sapiens 
     uncertain;
       ``(B) a human-animal embryo produced by fertilizing a human 
     egg with nonhuman sperm;
       ``(C) a human-animal embryo produced by fertilizing a 
     nonhuman egg with human sperm;
       ``(D) an embryo produced by introducing a nonhuman nucleus 
     into a human egg;
       ``(E) an embryo produced by introducing a human nucleus 
     into a nonhuman egg;
       ``(F) an embryo containing at least haploid sets of 
     chromosomes from both a human and a nonhuman life form;
       ``(G) a nonhuman life form engineered such that human 
     gametes develop within the body of a nonhuman life form;
       ``(H) a nonhuman life form engineered such that it contains 
     a human brain or a brain derived wholly or predominantly from 
     human neural tissues;
       ``(I) nonhuman life form engineered such that it exhibits 
     human facial features or other bodily morphologies to 
     resemble human features; or
       ``(J) an embryo produced by mixing human and nonhuman 
     cells, such that--
       ``(i) human gametes develop within the body of the 
     resultant organism;
       ``(ii) it contains a human brain or a brain derived wholly 
     or predominantly from human neural tissues; or
       ``(iii) it exhibits human facial features or other bodily 
     morphologies to resemble human features.

     ``Sec. 1132. Prohibition on certain human-animal chimeras

       ``(a) In General.--It shall be unlawful for any person to 
     knowingly, in or otherwise affecting interstate commerce--
       ``(1) create or attempt to create a prohibited human-animal 
     chimera;
       ``(2) transfer or attempt to transfer a human embryo into a 
     nonhuman womb;
       ``(3) transfer or attempt to transfer a nonhuman embryo 
     into a human womb; or
       ``(4) transport or receive for any purpose a prohibited 
     human-animal chimera.
       ``(b) Penalties.--
       ``(1) In general.--Whoever violates subsection (a) shall be 
     fined under this title, imprisoned not more than 10 years, or 
     both.
       ``(2) Civil penalty.--Whoever violates subsection (a) shall 
     be subject to a civil fine of the greater of--
       ``(A) $1,000,000; or
       ``(B) the amount equal to twice the amount of the gross 
     pecuniary gain, if any.
       ``(c) Rule of Construction.--This section does not prohibit 
     research involving the use of transgenic animal models 
     containing human genes or transplantation of human organs, 
     tissues, or cells into recipient animals, if such activities 
     are not prohibited under subsection (a).''.
       (b) Technical Amendment.--The table of chapters for part I 
     of title 18, United States Code, is amended by inserting 
     after the item relating to chapter 51 the following:

``52. Certain types of human-animal chimeras prohibited1131.''.........

  Mr. BRAUN. Madam President, in recent years, research involving 
human-animal hybrids has become much more prevalent. For example, in 
April, researchers in China created a monkey-human hybrid embryo that 
they allowed to grow and studied for weeks.
  I have serious ethical concerns with this type of human chimera 
research. My amendment would ban the practice by applying the NIH's 
current anti-chimera policy universally.
  Due to the dangerous and offensive nature of this research, my 
amendment imposes penalties on those who participate in this unethical 
research.
  We must act now. Just this morning, the International Society for 
Stem Cell Research, an international standards-setting body, issued 
guidance that permits the creation of human-animal hybrids. I ask that 
my Senate colleagues reject this foreign position and maintain our own 
NIH's ethical standards.
  All life is sacred. It is Congress's responsibility to enact 
commonsense bioethics.
  The PRESIDING OFFICER. The Senator's time has expired.
  Mr. BRAUN. Please support this amendment.
  The PRESIDING OFFICER. The senior Senator from Washington.
  Mrs. MURRAY. Madam President, I was just here yesterday reminding my 
colleagues that this is a bipartisan bill to help families across our 
country by boosting American's competitiveness. I have said it already. 
I will say it again. That means we have to ensure that American 
research is guided by science, not ideology.
  This amendment does the exact opposite and undermines scientifically 
significant research that could actually help develop new treatments 
and ultimately lead to lifesaving organ transplants.
  If we are serious about bipartisan commitment to American innovation, 
we have to stop these ideological attacks on medical research and focus 
on the science and ultimately the health of our patients.
  I urge a ``no'' vote. Thank you.


                       Vote on Amendment No. 1771

  The PRESIDING OFFICER. The question is on agreeing to the amendment.
  Mr. BRAUN. I ask for the yeas and nays.
  The PRESIDING OFFICER. Is there a sufficient second?
  There appears to be a sufficient second.
  The clerk will call the roll.
  The bill clerk called the roll.
  Mr. DURBIN. I announce that the Senator from West Virginia (Mr. 
Manchin) is necessarily absent.
  Mr. THUNE. The following Senators are necessarily absent: the Senator 
from Tennessee (Mrs. Blackburn) and the Senator from North Carolina 
(Mr. Tillis).
  The PRESIDING OFFICER. Are there any other Senators in the Chamber 
desiring to vote or change their vote?
  The result was announced--yeas 48, nays 49, as follows:

                      [Rollcall Vote No. 212 Leg.]

                                YEAS--48

     Barrasso
     Blunt
     Boozman
     Braun
     Burr
     Capito
     Cassidy
     Collins
     Cornyn
     Cotton
     Cramer
     Crapo
     Cruz
     Daines
     Ernst
     Fischer
     Graham
     Grassley
     Hagerty
     Hawley
     Hoeven
     Hyde-Smith
     Inhofe
     Johnson
     Kennedy
     Lankford
     Lee
     Lummis
     Marshall
     McConnell
     Moran
     Murkowski
     Paul
     Portman
     Risch
     Romney
     Rounds
     Rubio
     Sasse
     Scott (FL)
     Scott (SC)
     Shelby
     Sullivan
     Thune
     Toomey
     Tuberville
     Wicker
     Young

                                NAYS--49

     Baldwin
     Bennet
     Blumenthal
     Booker
     Brown
     Cantwell
     Cardin
     Carper
     Casey
     Coons
     Cortez Masto
     Duckworth
     Durbin
     Feinstein
     Gillibrand
     Hassan
     Heinrich
     Hickenlooper
     Hirono
     Kaine
     Kelly
     King
     Klobuchar
     Leahy
     Lujan
     Markey
     Menendez
     Merkley
     Murphy
     Murray
     Ossoff
     Padilla
     Peters
     Reed
     Rosen
     Sanders
     Schatz
     Schumer
     Shaheen
     Sinema
     Smith
     Stabenow
     Tester

[[Page S3495]]


     Van Hollen
     Warner
     Warnock
     Warren
     Whitehouse
     Wyden

                             NOT VOTING--3

     Blackburn
     Manchin
     Tillis
  The PRESIDING OFFICER. On this vote, the yeas are 48, the nays are 
49.
  Under the previous order requiring 60 votes for the adoption of this 
amendment, the amendment is rejected.
  The amendment (No. 1771) was rejected.
  The junior Senator from Kansas.


         Amendment No. 1973, as Modified, to Amendment No. 1502

  Mr. MARSHALL. Madam President, I call up my amendment No. 1973, as 
modified, with the changes at the desk and ask that it be reported by 
number.
  The PRESIDING OFFICER. The clerk will report the amendment.
  The senior assistant legislative clerk read as follows:

       The Senator from Kansas [Mr. Marshall] proposes an 
     amendment numbered 1973, as modified, to amendment No. 1502.

  The amendment, as modified, is as follows

  (Purpose: To express the sense of the Senate regarding the need to 
   conduct a comprehensive investigation to determine the origins of 
                   COVID-19, and for other purposes)

        At the appropriate place, insert the following:

     SEC. ____. FINDINGS AND SENSE OF THE SENATE REGARDING AN 
                   INVESTIGATION TO DETERMINE THE ORIGINS OF 
                   COVID-19.

       (a) Findings.--Congress finds the following:
       (1) COVID-19 has taken the lives of nearly 3,500,000 
     individuals around the world.
       (2) Understanding the origins of the COVID-19 pandemic is 
     essential to addressing our vulnerabilities and preventing 
     future crises.
       (3) In May 2020, the World Health Assembly did not 
     authorize a comprehensive investigation into the origins of 
     COVID-19, and instead passed a significantly limited 
     compromise resolution, with Chinese government support, which 
     did not explicitly include in its scope the possibility of a 
     research-related accident.
       (4) The 2020 World Health Assembly resolution and its terms 
     of reference, which were negotiated privately between the 
     World Health Organization (in this section referred to as 
     ``WHO'') and Chinese authorities, handed the Chinese 
     government control over the joint-study process by giving the 
     Chinese government veto power over which international 
     experts were allowed to participate in the joint study and by 
     agreeing that most primary research would be carried out by 
     Chinese teams without ensuring broad access to primary data 
     by international experts.
       (5) As a result of these terms, the significant structural, 
     procedural, and analytical shortcomings of the joint study, 
     and the severe restrictions imposed by Chinese authorities, 
     the WHO-convened joint study into the origins of COVID-19 was 
     prevented from providing a balanced consideration of the 
     multiple theories of the origin of COVID-19.
       (6) Only 4 of the 313 pages of the joint-study team report 
     and its annexes addressed the possibility of a laboratory 
     accident, and no thorough examination of the lab incident 
     hypothesis was carried out by the joint-study team.
       (7) Some of the international experts on the joint-study 
     team stated that they lacked the means and resources to 
     properly investigate the research-related accident 
     hypothesis, and they were neither able nor meant to do such a 
     full investigation but instead were acting as a ``study 
     review group''.
       (8) WHO Director-General Dr. Tedros Adhanom Ghebreyesus 
     commented on March 30, 2021, the day the joint-study report 
     was released, ``I do not believe that [the joint-study 
     team's] assessment [of a possible lab incident] was extensive 
     enough. Further data and studies will be needed to reach more 
     robust conclusions . . . potentially with additional missions 
     involving specialist experts, which I am ready to deploy.''.
       (9) The WHO Director-General further commented, ``As far as 
     WHO is concerned all hypotheses remain on the table . . . We 
     have not yet found the source of the virus, and we must 
     continue to follow the science and leave no stone unturned as 
     we do . . . It is clear that we need more research across a 
     range of areas, which will entail further field visits.''.
       (10) The March 30, 2021 Joint Statement on the WHO-convened 
     COVID-19 Origins Study by the United States and 13 other 
     countries recognized the severe shortcomings of the joint-
     study process and called for ``a transparent and independent 
     analysis and evaluation, free from interference and undue 
     influence.''.
       (11) In spite of the devastation the COVID-19 pandemic has 
     caused in the United States and around the world, no process 
     currently exists to ensure a comprehensive investigation into 
     the source of COVID-19.
       (12) Such an investigation is essential for ensuring this 
     type of crisis never happens again for the benefit of all 
     people, all nations, and future generations.
       (b) Sense of the Senate.--It is the sense of the Senate 
     that--
       (1) a comprehensive investigation to determine the origins 
     of COVID-19 must be conducted by WHO immediately, with access 
     to all relevant records, samples, and personnel in China, and 
     that such investigation must fully explore all possible 
     sources of the COVID-19 pandemic, including exclusively 
     ``natural'' zoonosis in the wild, human contamination in an 
     animal farm, and a research-related accident;
       (2) the United States delegation to the World Health 
     Assembly should, in concert with allies and partners around 
     the world, work to ensure that an international scientific 
     investigation into the origins of COVID-19, with full access 
     to all relevant records, samples, and personnel in China, 
     will be authorized by the World Health Assembly and 
     implemented with extreme urgency; and
       (3) should such a full investigation not be authorized by 
     the 2021 World Health Assembly, then the United States 
     Government should immediately begin planning a comprehensive 
     and data-driven investigation into the COVID-19 pandemic 
     origins, in concert with willing partner governments and 
     experts around the world.

  The PRESIDING OFFICER. There are now 2 minutes of debate, equally 
divided, on the amendment.
  Mr. MARSHALL. Madam President, over the past year, COVID-19 has 
spread to all corners of the world, killing more than 3 million people 
in its path, including more than 550,000 Americans. We were originally 
told this virus initiated in a wet market or that it may have come from 
a bat that directly infected a human. However, the preponderance of 
evidence now suggests this virus may have leaked from a lab in Wuhan.
  With the World Health Assembly meeting this week, I ask this body to 
fully express support for a complete investigation into this outbreak. 
It is outrageous and inconceivable that a comprehensive investigation 
has still not occurred.
  If China continues on its path of coverup, we must begin planning a 
full investigation, including with partners around the world. It would 
be utterly irresponsible to suffer through the worst pandemic in a 
century and not have the origins fully investigated.
  Our bipartisan amendment will deliver the message that the Chinese 
must show us the data and be transparent with the world, and if they 
don't, we will fight to get to the bottom of this pandemic.
  I thank Senator Gillibrand for introducing this amendment with me and 
ask that all Senators join us in approving it, and we hope, we believe, 
that this can pass with a voice vote.
  Thank you. And I yield.
  Mrs. GILLIBRAND. Mr. President, I yield back all time, and I support 
this amendment.
  The PRESIDING OFFICER. Without objection, all time is yielded back.


                       Vote on Amendment No. 1973

  Ms. CANTWELL. Madam President, I ask unanimous consent to vitiate the 
60-vote threshold for this amendment.
  The PRESIDING OFFICER. Is there objection?
  Without objection, it is so ordered.
  The question is on agreeing to the amendment.
  The amendment (No. 1973), as modified, was agreed to.
  The PRESIDING OFFICER. The Senator from Nebraska.


                Amendment No. 2023 to Amendment No. 1502

  Mr. SASSE. Madam President, I would like to call up my amendment No. 
2023 and ask that it be reported by number.
  The PRESIDING OFFICER. The clerk will report the amendment by number.
  The bill clerk read as follows:

       The Senator from Nebraska [Mr. Sasse] proposes amendment 
     numbered 2023 to amendment No. 1502.

  The amendment is as follows

(Purpose: To authorize appropriations for the Defense Advanced Research 
 Projects Agency to conduct research and development in key technology 
                              focus areas)

        At the appropriate place in division B, insert the 
     following:

     SEC. ___. AUTHORIZATION OF APPROPRIATIONS FOR THE DEFENSE 
                   ADVANCED RESEARCH PROJECTS AGENCY.

       (a) In General.--Notwithstanding any other provision of 
     law, there is authorized to be appropriated for the Defense 
     Advanced Research Projects Agency to conduct research and 
     development in key technology focus areas $3,500,000,000 for 
     each of fiscal years 2022 through 2026.
       (b) Supplement, Not Supplant.--Any amount appropriated 
     pursuant to the authorization in subsection (a) shall 
     supplement and not supplant any amounts already appropriated 
     for the Defense Advanced Research Projects Agency.


[[Page S3496]]


  The PRESIDING OFFICER. The Senator from Nebraska.
  Mr. SASSE. Madam President, my amendment about doubling DARPA funding 
is really simple: It doubles DARPA funding. This amendment would 
provide an additional $3.5 billion a year to the base, $3.5 billion 
that DARPA currently receives over the next 5 years.
  To members of the Armed Services Committee, I would tell you, this 
amendment doesn't do anything to mess with your base authorization. 
Your work is not displaced. This is simply additive. Modern war isn't 
just about enemy landings; it is also about enemy hackings. And the 
Chinese Communist Party is currently pouring money into machine 
learning, AI, and quantum because they think if they achieve first-
mover advantage in cyber, they will ultimately become the world's 
preeminent superpower. DARPA's job is to make sure that doesn't happen.
  We to need to make sure that Chairman Xi lies awake at night worrying 
about his critical infrastructure, his networks, and his 
vulnerabilities. And DARPA is currently doing that work, but DARPA is 
not funded for us to win the technology race.
  Money that goes to NSF, which is the core of the bill that is before 
us----
  The PRESIDING OFFICER. The Senator's time has expired.
  Mr. SASSE (continuing). Is important, but DARPA is different. DARPA 
is the one that leads Chairman Xi to be worried at night.
  I request a ``yes'' vote.
  The PRESIDING OFFICER. Who yields time?
  Mr. SASSE. I ask for a recorded vote, and I ask for the yeas and 
nays.


                       Vote on Amendment No. 2023

  The PRESIDING OFFICER. The question is on agreeing to the amendment.
  Is there a sufficient second?
  There is a sufficient second.
  The clerk will call the roll.
  The senior assistant legislative clerk called the roll.
  Mr. DURBIN. I announce that the Senator from West Virginia (Mr. 
Manchin) is necessarily absent.
  Mr. THUNE. The following Senators are necessarily absent: the Senator 
from Tennessee (Mrs. Blackburn) and the Senator from North Carolina 
(Mr. Tillis).
  The PRESIDING OFFICER. Are there any other Senators in the Chamber 
desiring to vote?
  The result was announced--yeas 67, nays 30, as follows:

                      [Rollcall Vote No. 213 Leg.]

                                YEAS--67

     Barrasso
     Bennet
     Blumenthal
     Blunt
     Boozman
     Burr
     Cantwell
     Capito
     Casey
     Collins
     Coons
     Cornyn
     Cortez Masto
     Cotton
     Cramer
     Cruz
     Daines
     Durbin
     Ernst
     Fischer
     Gillibrand
     Graham
     Hagerty
     Hassan
     Heinrich
     Hickenlooper
     Hoeven
     Hyde-Smith
     Inhofe
     Kaine
     Kelly
     Kennedy
     King
     Lujan
     Marshall
     McConnell
     Moran
     Murkowski
     Murphy
     Murray
     Ossoff
     Padilla
     Peters
     Portman
     Romney
     Rosen
     Rounds
     Rubio
     Sasse
     Schatz
     Schumer
     Scott (FL)
     Scott (SC)
     Shaheen
     Shelby
     Sinema
     Stabenow
     Sullivan
     Tester
     Thune
     Van Hollen
     Warner
     Warnock
     Warren
     Whitehouse
     Wicker
     Young

                                NAYS--30

     Baldwin
     Booker
     Braun
     Brown
     Cardin
     Carper
     Cassidy
     Crapo
     Duckworth
     Feinstein
     Grassley
     Hawley
     Hirono
     Johnson
     Klobuchar
     Lankford
     Leahy
     Lee
     Lummis
     Markey
     Menendez
     Merkley
     Paul
     Reed
     Risch
     Sanders
     Smith
     Toomey
     Tuberville
     Wyden

                             NOT VOTING--3

     Blackburn
     Manchin
     Tilli
  The PRESIDING OFFICER. On this vote, the yeas are 67, the nays are 
30.
  Under the previous order requiring 60 votes for the adoption of this 
amendment, the amendment is agreed to.
  The amendment (No. 2023) was agreed to.
  The PRESIDING OFFICER. The majority leader.

                          ____________________